Clinical Trials · NCT05870462
Semaglutide and Vascular Regeneration
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Canadian Medical and Surgical Knowledge Translation Research Group
- Enrollment
- 100
- Start date
- Apr 2023
- Locations
- 2 sites, Canada
- Primary endpoint
- Changes in the mean frequency (%) of circulating ALDHhiSSClow primitive progenitor cells in individuals treated with semaglutide versus usual care for 6 months